share_log

Clover Health Investments And 2 Other Stocks Under $1 Insiders Are Buying

Clover Health Investments And 2 Other Stocks Under $1 Insiders Are Buying

Clover Health Investments和其他2只低于1美元的股票内部人士正在买入
Benzinga ·  05/21 08:40

The Dow Jones index closed lower by 0.5% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道琼斯指数周一收盘下跌0.5%。当内部人士购买或出售股票时,这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将此视为他们整体投资或交易决策的一个因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是细价股最近几笔值得注意的内幕交易。欲了解更多信息,请访问Benzinga的内幕交易平台。

MultiPlan

多套餐

  • The Trade: MultiPlan Corporation (NYSE:MPLN) Director Anthony Colaluca Jr bought a total of 160,000 shares at an average price of $0.60. To acquire these shares, it cost around $96,000.
  • What's Happening: On May 8, MultiPlan posted a GAAP loss of 83 cents per share.
  • What MultiPlan Does: MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry.
  • 贸易:MultiPlan Corporation(纽约证券交易所代码:MPLN)董事小安东尼·科拉卢卡以0.60美元的平均价格共购买了16万股股票。收购这些股票的成本约为96,000美元。
  • 发生了什么:5月8日,MultiPlan公布的每股GAAP亏损为83美分。
  • MultiPlan的作用:MultiPlan Corp是一家数据分析和技术解决方案的提供商,旨在为美国医疗保健行业带来可负担性、效率和公平性。

Fresh Tracks Therapeutics

新曲目疗法

  • The Trade: Fresh Tracks Therapeutics, Inc. (OTC:FRTX) 10% owner Exploration Capital, LLC acquired a total of 74,565 shares at an average price of $0.92. To acquire these shares, it cost around $68,592.
  • What's Happening: The company's stock gained around 16% over the past six months.
  • 交易:Fresh Tracks Therapeutics, Inc.(场外交易代码:FRTX)10%的所有者Exploration Capital, LLC共收购了74,565股股票,平均价格为0.92美元。收购这些股票的成本约为68,592美元。
  • 发生了什么:该公司的股票在过去六个月中上涨了约16%。

Clover Health Investments

三叶草健康投资

  • The Trade: Clover Health Investments, Corp. (NASDAQ:CLOV) Director Anna U Loengard acquired a total of 27,085 shares at an average price of $0.94. The insider spent around $25,672 to buy those shares.
  • What's Happening: On May 7, Clover Health Investments reported better than expected first-quarter financial results.
  • What Clover Health Investments Does: Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant.
  • 交易:三叶草健康投资公司(纳斯达克股票代码:CLOV)董事安娜·罗恩加德共收购了27,085股股票,平均价格为0.94美元。知情人士花费了约25,672美元购买了这些股票。
  • 发生了什么:5月7日,三叶草健康投资公布的第一季度财务业绩好于预期。
  • 三叶草健康投资的所作所为:三叶草健康投资公司是一家医疗保健技术公司。它专注于通过其专有软件平台Clover Assistant使医疗保险医生能够主动管理慢性病。

Read More: Jim Cramer Says This Materials Stock Is A 'Great Spec,' Plus He Recommends Buying Abercrombie & Fitch

阅读更多:吉姆·克莱默说这种材料股是 “很好的规格”,而且他建议买入Abercrombie & Fitch

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发